Form 10-Q · Quarterly report
Parker Hannifin 10-Q, filed Nov 5, 2026
- Filed
- CIK
- 0000076334
- Accession no.
- 0000076334-26-000172
Summary
Parker Hannifin reported net sales of $5.992 billion for the quarter ended September 30, 2026, up 17.9% from a year earlier, and net income of $884 million, up from $808 million. The company said organic sales grew 11.5%, with growth in both Diversified Industrial and Aerospace Systems and contributions from the FGC and Curtis acquisitions.
Key points
- Net sales rose 17.9% to $5.992 billion, including approximately $349 million from the FGC and Curtis acquisitions and 11.5% organic sales growth.
- Net income was $884 million, compared with $808 million in the prior-year quarter.
- Diversified Industrial sales grew 20.6% to $4.152 billion, and Aerospace Systems sales rose to $1.867 billion.
- Parker expects a fiscal 2027 effective tax rate of about 22.5% and plans roughly $75 million in business realignment and $35 million in acquisition integration charges over the remainder of fiscal 2027.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview The Company is a global leader in motion and control technologies. Leveraging a unique combination of interconnected technologies, we design, manufacture, and provide aftermarket support for highly engineered solutions that create value for customers primarily in aerospace and defense, in-plant and industrial equipment, transportation, off-highway, energy, and HVAC and refrigeration markets around the world. By aligning around our purpose, Enabling Engineering Breakthroughs that Lead to a Better Tomorrow, Parker is better positioned for the challenges and opportunities of tomorrow. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.